Medical Oncology

Uzm. Dr. Ender Kalacı

Doctor and researcher Liv Hospital Ankara Ankara
Bone Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: livhospital.com.

  • Gastrointestinal sistem tümörleri (Kolorektal kanser, Mide kanseri, Özofagus kanseri)
  • Jinekolojik Kanserler (Over kanseri, Serviks kanseri, Endometrium kanseri)
  • Sarkomlar (yumuşak doku ve kemik sarkomları)
  • Meme kanseri
  • Akciğer kanseri
  • Moleküler onkoloji ve kişiselleştirilmiş tedavi yaklaşımları
  • Geriatrik onkoloji
  • Palyatif Bakım
  • Kanser taraması ve erken tanı programları
  • Kanser Önleme

CV

Education and experience

From source

Experience

  • 2018-2019Niğde Ömer Halisdemir Eğitim ve Araştırma Hastanesi, İç Hastalıkları Uzmanı (Devlet Hizmet Yükümlülüğü)livhospital.com
  • ExperienceBitlis Tatvan Devlet Hastanesi, Tıbbi Onkoloji Uzmanı (Devlet Hizmet Yükümlülüğü), 2023 Ağustos – 2024 Haziranlivhospital.com

Education

  • 2019-2023Ankara Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Tıbbi Onkoloji Bilim Dalı, Ankara, TÜRKİYE, Tıbbi Onkoloji Yan dal Uzmanlık Eğitimilivhospital.com
  • 2014-2018Ankara Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Ankara, TÜRKİYE, İç Hastalıkları Uzmanlık Eğitimilivhospital.com
  • 2006-2012Akdeniz Üniversitesi Tıp Fakültesi, Antalya, TÜRKİYE, Tıp Fakültesilivhospital.com

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologylivhospital.comFrom source
  • InstitutionLiv Hospital Ankaralivhospital.comFrom source
  • Area of workBone NeoplasmsExtracted from 2 publications · Model version —From source
  • Publications15 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 21:06https://www.livhospital.com/uzm-dr-ender-kalacilivhospital.com

Scientific work

Publications on Bone Neoplasms

15 publications

  1. Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study)

    Clinical & Translational Oncology, 2026

    DOI 10.1007/s12094-026-04494-3 PMID 42400766 Source: OpenAlex

  2. Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature

    Clinical Genitourinary Cancer, 2026

    DOI 10.1016/j.clgc.2026.102594 PMID 42349378 Source: OpenAlex

  3. Clinicopathological Correlates of High Stromal Tumor-infiltrating Lymphocytes in Luminal Breast Cancer: A Real-world Study

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-3-11 Open-access full textSource: OpenAlex

  4. Cancer treatment outcomes in solid organ transplant recipients: a single-center retrospective cohort study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16789-3 Source: OpenAlex

  5. Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis

    Medicina, 2025

    DOI 10.3390/medicina61010123 PMID 39859105 10 citations (Europe PMC) Open-access full textSource: OpenAlex

  6. Real-world treatment compliance and outcomes in adult patients with localized Ewing sarcoma: A single-institution retrospective study

    Medicine, 2025

    DOI 10.1097/md.0000000000043405 PMID 40696651 Open-access full textSource: OpenAlex

  7. Characteristic features and prognostic factors in gastric cancer patients with bone metastases: multicenter experience

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2358458 PMID 38803194 Source: OpenAlex

  8. Akut Lenfoblastik Lösemide Allojenik Hematopoietik Kök Hücre Nakli Sonrası Sitomegalovirüs Reaktivasyonunun Etkileri: Retrospektif Bir Analiz

    LLM Dergi, 2024

    DOI 10.5578/llm.202402138 Source: OpenAlex

  9. Nivolumab-induced immune-related neutropenia in a renal cell carcinoma patient

    Journal of Oncology Pharmacy Practice, 2023

    DOI 10.1177/10781552231186748 PMID 37401253 1 citation (Europe PMC) Source: OpenAlex

  10. The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer

    Tuberkuloz ve Toraks, 2022

    DOI 10.5578/tt.20229803 PMID 35785877 Source: OpenAlex

View all 15 publications